Skip to main content
. 2022 Sep 27;14(9):e29652. doi: 10.7759/cureus.29652

Figure 2. How different drugs with different mechanisms can result in euglycemic DKA when taken with SGLT2 inhibitors.

Figure 2

DPP4 - dipeptidyl peptidase 4; GLP1 r - glucagon-like peptide 1 receptor; IRS - insulin receptor substrate; CTLA4 - cytotoxic T lymphocyte-associated protein 4; PD - programmed death; PDL - programmed death ligand; SGLT2 - sodium-glucose cotransporter-2; DKA - diabetic ketoacidosis